DeutschNewstral
Article
Philly.com on 2015-07-28 12:34
Teva buying Allergan, drops Mylan bid
Related news
Israel’s Teva drops bid for Mylan, buys Allergan for $40.5Btriblive.com
Teva drops bid for Mylan, buys Allergan generic drug company for $40.5 billionpost-gazette.com
Teva abandons Mylan takeover bid in favor of Allergan dealobserver-reporter.com
Teva Pharmaceutical Industries to buy Allergan Plc’s generic drug business for US$40.5 billion, drops Mylan bidbusiness.financialpost.com
Teva drops bid for Mylan, buys Allergan's generic drug unitbizjournals.com
Teva to buy Allergan generic business for $40.5 billion, drops Mylan bidReuters
Teva to buy Allergan generic drug business for $40.5-billion, drops Mylan bidThe Globe and Mail- Teva takes its case for buying Mylan to the company's stockholdersbizjournals.com
- Teva drops bid for Mylan, buys Allergan's generic drug unit for $40.5 billionbizjournals.com
- Teva ends hostile bid for Mylanbizjournals.com
Teva makes $40.1B unsolicited bid for MylanThe Salt Lake Tribune
Teva buys Allergan for $40.5b.Ynetnews- Mylan rejects Teva Pharmaceutical's takeover bidpost-gazette.com
- Teva accuses Mylan of suppressing bidThe Salt Lake Tribune
Allergan selling generics to Tevanwaonline.com
Israel's Teva buys Allergan generic drug company for $40.5BStar Telegram- Teva stock surges on Allergan dealbizjournals.com
Mylan foundation to block Teva pharma’s hostile takeover bidtimesofisrael.com
Teva accuses Mylan of ‘desperate attempt’ to suppress bidThe Findlay Courier